No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction.

M. Leusink, C.E. de Keyser, N.C. Onland-Moret, A. Hofman, L.E. Visser, B.H.Ch Stricker, P.I.W. de Bakker, A. Boer, R.H. van Schaik, A.H. Maitland-van der Zee

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1471-1477
Number of pages7
JournalPharmacogenomics
Volume15
Issue number11
DOIs
Publication statusPublished - 2014

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this